SHA:603590 Market Cap

SHA:603590 has a market cap or net worth of 6.32 billion as of March 9, 2026. Its market cap has increased by 66.76% in one year.

Market Cap

6.32B

Enterprise Value

5.97B

Revenue

871.31M

Ranking

n/a

PE Ratio

109.23

Stock Price

40.42

Market Cap Chart

Since August 27, 2018, SHA:603590's market cap has increased from 5.61B to 6.32B, an increase of 12.62%. That is a compound annual growth rate of 1.59%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	6.32B	-0.08%
Dec 31, 2025	6.32B	69.72%
Dec 31, 2024	3.72B	-37.51%
Dec 29, 2023	5.96B	52.69%
Dec 30, 2022	3.90B	-23.24%
Dec 31, 2021	5.08B	-12.98%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lifecome Biochemistry	6.55B
Shanghai OPM Biosciences	6.37B
Shenzhen Weiguang Biological Products	6.66B
GemPharmatech	6.30B
R&G PharmaStudies	6.30B
Xiangxue Pharmaceutical	6.25B
Kexing Biopharm	5.97B
Jiangsu Aidea Pharmaceutical Group	7.13B

Market Cap Rankings